Sign inJoin waitlistJoin the waitlist

Olivia Lara

Assistant Professor, Gynecologic Oncology · University of North Carolina Hospitals

Credentials: · · · · · ·

History

University of North Carolina Hospitals
Present
University of Texas M D Anderson Cancer Center
Present

New York University
2019–2022
Gynecologic Oncology
NYU Grossman School of Medicine
2019–2022
University of Texas Health Science Center at Houston
2017–2019
University of Texas M D Anderson Cancer Center
Obstetrics and Gynecology
University of Texas at Austin Dell Medical School
2013–2017
University of Texas School of Medicine at San Antonio
2009–2013

Research

Molecular Analysis of Clinically Defined Subsets of High-Grade Serous Ovarian Cancer
Cell Reports · 2020 · 87 citations
COVID-19 outcomes of patients with gynecologic cancer in New York City
Cancer · 2020 · First of 13 authors · 49 citations
Therapeutic Antisense Oligonucleotides in Oncology: From Bench to Bedside
Review · Cancers · 2024 · 46 citations

Bhavana Pothuri
10 papers
Anil Sood
8 papers
Victoria Bae-Jump
6 papers
Jason Wright
5 papers
Anne Knisely
4 papers · 4 as a resident
Benjamin Albright
4 papers
Jennifer McEachron
4 papers · 4 as a fellow
Julia Fehniger
4 papers · 4 as a fellow
Kari Hacker
4 papers
Lisa Gabor
4 papers · 4 as a fellow
NS
Nikita Sinha
4 papers
RC
Robert Coleman
4 papers

Clinical trials

Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
Site PI · Recruiting · Phase 3
National Cancer Institute (NCI)
2026–2028
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Site PI · Recruiting · Phase 3
NRG Oncology
2025–2034
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
Site PI · Recruiting
NRG Oncology
2020–2047